Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Nov 12, 2015 · 10-Q · 43 days after period end · 0001564590-15-010614
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Net Income | -$4.55M | -$4.91M | -$10.05M | -$5.92M |
| EPS Diluted | $0.16 | -$0.23 | -$0.68 | $0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 12, 2015 · 43 d after period end
